West Newton, MA, United States of America

Mark J Cartwright

USPTO Granted Patents = 23 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 10)

Average Co-Inventor Count = 5.9

ph-index = 6

Forward Citations = 120(Granted Patents)

Company Filing History:

Boston Medical Center Corporation

patents

Years Active: 2003-2024

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11884724 - Anti-PD-L1 antibodies and uses thereof (2024-01-30),

2. 11807677 - Microbe-binding molecules and uses thereof (2023-11-07),

3. 11795212 - Engineered microbe-targeting molecules and uses thereof (2023-10-24),

4. 11718651 - CRP capture/detection of gram positive bacteria (2023-08-08),

5. 11638748 - Pathogen vaccines and methods of producing and using the same (2023-05-02),

6. 11236149 - Microbe-binding molecules and uses thereof (2022-02-01),

7. 11209432 - Assays for antimicrobial activity and applications thereof (2021-12-28),

8. 11034744 - CRP capture/detection of gram positive bacteria (2021-06-15),

9. 10865235 - Engineered microbe-targeting molecules and uses thereof (2020-12-15),

10. 10813988 - Pathogen vaccines and methods of producing and using the same (2020-10-27),

11. 10759856 - Anti-PD-L1 antibodies and uses thereof (2020-09-01),

12. 10718766 - Assays for antimicrobial activity and applications thereof (2020-07-21),

13. 10696733 - Microbe-binding molecules and uses thereof (2020-06-30),

14. 10551379 - Methods and compositions for improving detection and/or capture of a target entity (2020-02-04),

15. 10526399 - Engineered microbe-targeting molecules and uses thereof (2020-01-07),

Title: **Mark J. Cartwright: Innovator in Immunotherapy and Microbial Detection**

Introduction

Mark J. Cartwright, based in West Newton, MA, is an accomplished inventor with an impressive portfolio of 23 patents. His innovative work predominantly focuses on the fields of immunotherapy and microbial detection, showcasing significant advancements that cater to various medical and environmental challenges.

Latest Patents

Among his notable contributions, Cartwright's latest patents include:

1. **Anti-PD-L1 Antibodies and Uses Thereof**

This patent relates to anti-PD-L1 antibodies or their antigen-binding fragments, as well as nucleic acids encoding these antibodies. The therapeutic compositions aim to enhance T-cell function, upregulating cell-mediated immune responses to treat T cell dysfunctional disorders, including tumor immunity and cancer.

2. **Microbe-Binding Molecules and Uses Thereof**

This patent introduces engineered microbe-targeting molecules and articles that significantly improve the detection of microbes. The technology offers enhanced sensitivity and signal intensity for various applications, including diagnostics and therapeutic agents against infections caused by microbes.

Career Highlights

Mark J. Cartwright has held prestigious positions in renowned organizations such as President and Fellows of Harvard College and Merck Patent GmbH. His work in these institutions has contributed to groundbreaking advancements in medical science and technology, solidifying his reputation in the field.

Collaborations

Throughout his career, Cartwright has collaborated with esteemed colleagues, including Michael Super and Donald Elliot Ingber. These partnerships have fostered innovative ideas and projects, enhancing the scope and impact of his inventions.

Conclusion

Mark J. Cartwright exemplifies dedication and innovation in his work, with a focus on enhancing therapeutic techniques and detection methods in healthcare. His 23 patents serve as a testament to his commitment to fostering advancements in immunotherapy and microbial detection, making significant contributions to the scientific community.

This text is generated by artificial intelligence and may not be accurate.